Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Stroke. 2021 Mar 4;52(4):1339–1346. doi: 10.1161/STROKEAHA.120.031216

Table 4:

Multivariate logistic analysis. Association of sociodemographic factors with vascular risk factor at goal and use of stroke preventive drugs agents among stroke/TIA participants.

HTN at Goal
OR (95% CI) (n=387)
Diabetes at Goal
OR (95% CI) (n=380)
Dyslipidemia at Goal
OR (95% CI) (n=378)
Atrial Fibrillation on anticoagulation
OR (95% CI) (n=380)
On Treatment with Antithrombotics
OR (95% CI) (n=388)
On Treatment with Statins
OR (95% CI) (n=380)
On Treatment with Antithrombotics and statins
OR (95% CI) (n=388)
Age* 0.95(0.92–0.97) 0.96(0.93–0.99) 0.98(0.95–1.01) 0.99(0.93–1.05) 1.06(1.03–1.08) 1.08(1.05–1.11) 1.06(1.03–1.10)
Female 0.79(0.42–1.48) 1.19(0.58–2.46) 0.49(0.28–0.86) 0.56(0.16–1.95) 1.16(0.65–2.07) 1.06(0.57–1.98) 0.88(0.46–1.71)
>High School 0.55(0.29–1.03) 1.83(0.87–3.88) 0.67(0.39–1.17) 0.65(0.16–2.63) 1.03(0.55–1.94) 0.99(0.50–1.93) 1.12(0.54–2.32)
Income >20,000 1.15(0.58–2.30) 1.32(0.64–2.73) 0.88(0.45–1.75) 1.61(0.54–4.81) 0.68(0.37–1.23) 1.40(0.77–2.56) 1.08(0.55–2.15)
English as preferred language 1.28(0.57–2.90) 0.25(0.12–0.55) 0.91(0.43–1.96) 2.63(0.58–11.95) 1.28(0.64–2.53) 1.26(0.60–2.66) 1.05(0.49–2.21)
Immigrant ≥10 years in the US** 1.21(0.45–3.22) 0.06(0.01–0.32) 0.66(0.27–1.60) 0.18(0.04–0.70) 1.66(0.63–4.37) 1.44(0.52–3.94) 1.53(0.50–4.67)
US born** 2.27(0.52–9.85) 0.03(0.00–0.24) 0.91(0.30–2.76) 3.58(0.40–32.09) 3.21(0.93–11.13) 2.01(0.54–7.53) 3.26(0.78–13.64)
No Health Insurance 1.43(0.69–2.99) 1.39(0.55–3.49) 0.42(0.18–0.95) 0.47(0.05–4.42) 0.91(0.47–1.77) 0.47(0.23–0.97) 0.66(0.30–1.44)

Each variable was adjusted by the rest of the variables included in the table.

*

Per year

**

Immigrant <10 years in the US as reference